[18F]Fluorodeoxyglucose Positron Emission Tomography Correlates With Akt Pathway Activity but Is Not Predictive of Clinical Outcome During mTOR Inhibitor Therapy We conducted the first phase 0 ...
A phase I trial of the histone deacetylase inhibitor panobinostat (LBH589) and epirubicin in patients with solid tumor malignancies. A phase I study of EP-100, a luteinizing hormone releasing hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results